FonesLife

FonesLife is a Japan-based preventive healthcare and health diagnostics company that uses large-scale blood proteomics and AI-driven analytics to visualize current health status and estimate future disease risk. The company commercializes FonesVisuas, a blood testing service that analyzes roughly 7,000 proteins and provides risk forecasting and personalized health improvement recommendations. FonesLife also operates a proteomics lab and offers SomaScan-based assay services for research and development customers as Japan's first SomaLogic Certified Site. Its business sits at the intersection of digital health, diagnostics, and translational proteomics rather than therapeutic drug development. The company appears focused on consumer, medical institution, employer, and research use cases, with an emphasis on prevention and behavioral change.